| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Biochemistry and Molecular Biology and University of Southern California Norris Comprehensive Cancer Center, University of Southern California School of Medicine, Los Angeles, California 90033
Disintegrins are Arg-Gly-Asp-containing proteins that inhibit integrin-mediated cell-cell and cell-matrix interactions. We have purified a disintegrin, contortrostatin, from Agkistrodon contortrix contortrix snake venom that is a potent inhibitor of human metastatic melanoma (M24 met) cell adhesion to extracellular matrix proteins. Contortrostatin inhibits M24 met cell adhesion to type I collagen, vitronectin, and fibronectin with 50% inhibitory concentration values of 20, 75, and 220 nM, respectively. Contortrostatin does not significantly inhibit adhesion of M24 met cells to laminin. 125I-labeled contortrostatin binds to M24 met cells in a saturable and displaceable manner. Scatchard analysis indicates that there are two binding sites for 125I-labeled contortrostatin on the surface of these cells. High affinity binding has a Kd of 3 nM with 165,000 sites/cell; low affinity binding has a Kd of 60 nM with 500,000 sites/cell. Immobilized contortrostatin can support adhesion of M24 met cells; this binding is blocked by a monoclonal antibody to the ß1 integrin subunit and by an antibody to the fibronectin receptor
5ß1. The anti-vitronectin receptor (
vß5) monoclonal antibody which blocks adhesion of M24 met cells to immobilized vitronectin does not block binding of M24 met cells to immobilized contortrostatin. In an in vivo experimental metastasis model system, contortrostatin at 20 µg and 100 µg inhibits lung colonization of M24 met cells (5 x 105), injected in the tail vein of scid mice, by 51 and 73%, respectively. We conclude that contortrostatin is a potent inhibitor of ß1 integrin-mediated M24 met cell adhesion in vitro and that it also inhibits lung colonization in vivo.
1 This work was supported by NIH Department of Health and Human Services Grants CA54861 (F. S. M., Y. A. D.) and CA42919 (Y. A. D).
2 To whom requests for reprints should be addressed, at University of Southern California School of Medicine, Cancer Research Laboratory #106, 1303 North Mission Road, Los Angeles, CA 90033.
Received 2/ 3/94. Accepted 7/20/94.
This article has been cited by other articles:
![]() |
M. Edderkaoui, P. Hong, J. K. Lee, S. J. Pandol, and A. S. Gukovskaya Insulin-like Growth Factor-I Receptor Mediates the Prosurvival Effect of Fibronectin J. Biol. Chem., September 14, 2007; 282(37): 26646 - 26655. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oxelmark, J. M. Roth, P. C. Brooks, S. E. Braunstein, R. J. Schneider, and M. J. Garabedian The Cochaperone p23 Differentially Regulates Estrogen Receptor Target Genes and Promotes Tumor Cell Adhesion and Invasion. Mol. Cell. Biol., July 1, 2006; 26(14): 5205 - 5213. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Cominetti, C. H. B. Terruggi, O. H. P. Ramos, J. W. Fox, A. Mariano-Oliveira, M. S. De Freitas, C. C. Figueiredo, V. Morandi, and H. S. Selistre-de-Araujo Alternagin-C, a Disintegrin-like Protein, Induces Vascular Endothelial Cell Growth Factor (VEGF) Expression and Endothelial Cell Proliferation in Vitro J. Biol. Chem., April 30, 2004; 279(18): 18247 - 18255. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Swenson, F. Costa, R. Minea, R. P. Sherwin, W. Ernst, G. Fujii, D. Yang, and F. S. Markland Jr. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression Mol. Cancer Ther., April 1, 2004; 3(4): 499 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Palmantier, M. D. George, S. K. Akiyama, F. M. Wolber, K. Olden, and J. D. Roberts cis-Polyunsaturated Fatty Acids Stimulate {beta}1 Integrin-mediated Adhesion ofHuman Breast Carcinoma Cells to Type IV Collagen by Activating ProteinKinases C-{{epsilon}} and -{micro} Cancer Res., March 1, 2001; 61(6): 2445 - 2452. [Abstract] [Full Text] |
||||
![]() |
I.-C. Kang, Y.-D. Lee, and D.-S. Kim A Novel Disintegrin Salmosin Inhibits Tumor Angiogenesis Cancer Res., August 1, 1999; 59(15): 3754 - 3760. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Marcinkiewicz, J. J. Calvete, M. M. Marcinkiewicz, M. Raida, S. Vijay-Kumar, Z. Huang, R. R. Lobb, and S. Niewiarowski EC3, a Novel Heterodimeric Disintegrin from Echis carinatus Venom, Inhibits alpha 4 and alpha 5 Integrins in an RGD-independent Manner J. Biol. Chem., April 30, 1999; 274(18): 12468 - 12473. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Johnson and B. Shur The level of cell surface beta1,4-galactosyltransferase I influences the invasive potential of murine melanoma cells J. Cell Sci., January 8, 1999; 112(16): 2785 - 2795. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |